Valeant Pharmaceuticals Announces Planned Management Departure - 21 News Now, More Local News for Youngstown, Ohio -

Valeant Pharmaceuticals Announces Planned Management Departure

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Valeant Pharmaceuticals International, Inc.

LAVAL, Quebec, June 13, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) today announced that Ryan Weldon, Valeant's Executive Vice President and Company Group Chairman, will be leaving the Company following the divestiture of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant to Nestlé S.A.  Nestle expects to complete its acquisition of Galderma S.A. in July and would expect to operate the acquired assets through Galderma. 

"The Board of Directors and I appreciate the significant contributions Ryan has made during his time with Valeant, especially his efforts through the Medicis integration and his tireless dedication with the aesthetic and dermatology communities," said J. Michael Pearson, chairman and chief executive officer.  "As a clear testament to the performance of Valeant's aesthetic commercial team, Galderma is in discussions with the injectable team to discuss long-term opportunities.  Although his leadership will be missed, the company has created and developed a strong management team and I am confident Ryan will assist us successfully through this transition period."

"The last six years at Valeant has been an extraordinary experience," said Ryan Weldon.  "It has been a privilege to work with Mike, my fellow Valeant employees, and the Board on this journey."

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology  and branded generics. More information about Valeant can be found at www.valeant.com.

Forward-looking Statements

This press release may contain forward-looking statements, including, but not limited to, statements regarding the long-term opportunities at Galderma for the aesthetics team. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the company's most recent annual or quarterly report filed with the Securities and Exchange Commission ("SEC") and other risks and uncertainties detailed from time to time in the Company's filings with the SEC and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Valeant undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.

Contact Information:
Valeant Pharmaceuticals:
Investors:                                                                   
Laurie W. Little
Valeant Pharmaceuticals International, Inc.                                                       
949-461-6002                                                             
laurie.little@valeant.com                                           

Media:
Renee E. Soto/Meghan Gavigan
Sard Verbinnen & Co.
212-687-8080
rsoto@sardverb.com / mgavigan@sardverb.com

Valeant Pharmaceuticals International, Inc.

 Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

©2012 PR Newswire. All Rights Reserved.

  • More From wfmj.comMore>>

  • Ocean crash kills teen pilot seeking world record

    Ocean crash kills teen pilot seeking world record

    Wednesday, July 23 2014 10:03 PM EDT2014-07-24 02:03:01 GMT
    A family spokeswoman says an Indiana teenager was killed when his plane crashed while trying to set a record for an around-the-world flight.More >>
    His pilot's license fresh in his hands, an Indiana teenager set out in June for the adventure of a lifetime: an around-the-world flight with his father designed to break a record and raise money to build schools in his...More >>
  • Ohio veteran cited for ducks hopes for law change

    Ohio veteran cited for ducks hopes for law change

    Wednesday, July 23 2014 9:56 PM EDT2014-07-24 01:56:55 GMT
    COSHOCTON, Ohio (AP) - An Army veteran who says his pet ducks help relieve his post-traumatic stress disorder is now hoping for a change in the Ohio village law that prohibits him from keeping the animals in his backyard. Darin Welker, who served in the Army National Guard, was cited for violating a ban on keeping farm animals in West Lafayette. The village is about 80 miles east of Columbus. Welker and his attorney said Wednesday that village officials are considering the possibility of a n...More >>
    COSHOCTON, Ohio (AP) - An Army veteran who says his pet ducks help relieve his post-traumatic stress disorder is now hoping for a change in the Ohio village law that prohibits him from keeping the animals in his backyard. Darin Welker, who served in the Army National Guard, was cited for violating a ban on keeping farm animals in West Lafayette. The village is about 80 miles east of Columbus. Welker and his attorney said Wednesday that village officials are considering the possibility of a n...More >>
  • More than 500 migrant children sent to Pa.

    More than 500 migrant children sent to Pa.

    Wednesday, July 23 2014 9:31 PM EDT2014-07-24 01:31:15 GMT
    HARRISBURG, Pa. (AP) - More than 500 migrant children are being housed in Pennsylvania as federal officials wrestle with a national crisis created by a flood of tens of thousands of unaccompanied minors across the southern U.S. border. State officials confirmed Wednesday that the federal government told them 120 children are in two temporary centers in Bethlehem and Womelsdorf, near Reading. Kait Gillis of the state Department of Public Welfare says the other 386 youngsters are staying with ...More >>
    HARRISBURG, Pa. (AP) - More than 500 migrant children are being housed in Pennsylvania as federal officials wrestle with a national crisis created by a flood of tens of thousands of unaccompanied minors across the southern U.S. border. State officials confirmed Wednesday that the federal government told them 120 children are in two temporary centers in Bethlehem and Womelsdorf, near Reading. Kait Gillis of the state Department of Public Welfare says the other 386 youngsters are staying with ...More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 Worldnow and WFMJ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms